In the decade since the FDA cleared the first deep brain stimulation device to treat symptoms of Parkinson’s disease (Medtronic’s Activa), it’s become established a safe, effective option along the spectrum of care. But Geoff Thrope, the founder and managing director of venture and commercialization firm NDI Medical LLC, said that technology hasn’t changed much […]
NDI Medical, a company that invests in, develops and commercializes neurotechnology devices, has opened an office in Minneapolis, its third. The move makes plenty of sense for NDI, and puts it in close proximity to Minnesota-based medical device giants Medtronic and St. Jude Medical, which represent potential exits for NDI’s portfolio of neurotechnology companies. NDI’s […]
Assuming all goes well in a federal regulatory review, neurotechnology startup SPR Therapeutics expects to begin commercializing its first product, a pain relief device, by the end of the year. Year-old SPR (it stands for “stimulation for pain relief”) is one of the newest members of the Cleveland area’s growing cluster of neurotechnology firms. The […]
Checkpoint Surgical, which has developed an intraoperative nerve stimulation device, is about a third of the way to completing a $3 million series B investment round. The suburban Cleveland company hopes to close the round by year’s end. Checkpoint would use the funding to boost its sales and marketing staff, more than doubling its employees […]
Northeast Ohio has a new healthcare-focused venture fund that's being led by a familiar name. Neurotechnology incubator NDI Medical, best known for the $42 million sale of a urinary incontinence-treating product to Medtronic in 2008, has started NDI Healthcare Fund with the help of $2 million in funding through Ohio's Third Frontier technology acceleration program.
Cleveland Clinic neuromodulation spinoff Intelect Medical may have stealthily exited Cleveland to set up shop in Boston, but the company's recent $78 million sale to Boston Scientific (NYSE: BSX) highlights Northeast Ohio's growing strength in neurotechnology. Here's a brief overview of the key players in Northeast Ohio's rising neurotechnology industry.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Checkpoint Surgical has begun a national launch of its handheld medical device used to identify nerves during surgery. The Checkpoint Stimulator/Locator stimulates motor nerves so surgeons can avoid damaging them during surgery. The device also helps physicians gauge nerve and muscle health. The device cleared for sale by the Food and Drug Administration in October […]
Maria Bennett has never been your generic biomedical engineer. Now, she's also the chief executive of a company working to develop and market a neurostimulation device aimed at alleviating shoulder pain for stroke patients.
Innovation in medical devices. Innovation in vaccines. Even innovation in regulating drug development -- MedCity News saw it all last week.
NDI Medical LLC has raised $2.1 million to continue developing nerve-stimulating devices to answer patient needs and improve their health care. The Highland Hills company recently spun out two technologies -- one identifies nerves and muscles during surgery; the other stimulates nerves to relieve chronic pain.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
